Sponsored Links
| Adaptimmune Announces Opening Of Phase I/II Clinical Trial For Metastatic Melanoma At Washington University, St. Louis |
 |
 |
 |
| Medical News - Clinical Trials and Drug Trials | |||
|
Adaptimmune announced today that it has opened a Phase I/II, two cohort, open label clinical trial in metastatic melanoma at Washington University, St. Louis, Missouri. Adaptimmune is focused on the use of T-cell therapy to treat cancer, with the body's own machinery - the T lymphocyte -- a cell that is being used to target and destroy cancerous cells... Read more: Clinical Trials / Drug Trials News From Medical News Today
|